OCON Therapeutics
PrivateLast Round
VC Round
Jun 24, 2024
Total Funding Raised
$1.7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
OCON Therapeutics is a health tech and life sciences company that develops, manufactures, and commercializes intrauterine drug-delivery technologies for women's health.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OCON Therapeutics Comparables
Compare OCON Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eurogine S.L. | 80% | |
| Sebela Pharmaceuticals | 78% | |
| 3Daughters | 78% |
OCON Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 24, 2024 | ||||
| VC Round | Dec 18, 2020 | ||||
| VC Round | Jun 22, 2020 | ||||
| Strategic | Oct 19, 2017 | ||||
| Seed | May 7, 2013 |
OCON Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Exerte Partners | VC Round |
| Israel Innovation Authority | VC Round |
| Features Capital | VC Round |
| Astia Angels | VC Round |
| Pontifax Venture Capital | VC Round, Seed |
| Docor International Management | VC Round, Seed |
| RH Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 833% MoM, from 278 to 2.6K.
- Dec 18, 2020
Rhia Ventures led the round with participation from Pontifax, Astia Angels, and Israel Innovation Authority.
OCON Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about OCON Therapeutics's valuation, stock price, and market status.
Is OCON Therapeutics a public or private company?
OCON Therapeutics is a private company.
What is the current stock price of OCON Therapeutics?
OCON Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is OCON Therapeutics worth (valuation)?
Valuation information for OCON Therapeutics is not publicly available.
Can I buy OCON Therapeutics stock?
OCON Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was OCON Therapeutics's last funding round?
OCON Therapeutics's most recent funding round was Early Funding on June 24, 2024.
Who are the main investors in OCON Therapeutics?
Key investors in OCON Therapeutics include RH Capital.
Will OCON Therapeutics IPO soon?
No public IPO plans have been announced for OCON Therapeutics.
How can I track OCON Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor OCON Therapeutics's secondary market activity and sign up for updates.